INNATE PHARMA S A (IPHA): Institutional Ownership
Hedge funds and institutional managers reporting a position in IPHA · Health Care. Based on the most recent 13F filing from each holder, sourced from SEC EDGAR.
Reported Holders
2
13F filers
Aggregate Value
$71K
Across holders
Last Price
$1.79
2026-06-26
Sector
Health Care
GICS
Holder activity1 new0 added1 reduced
| Manager⇅ | Type⇅ | Shares⇅ | Market Value▼ | % of Total⇅ | % of Portfolio⇅ | Action⇅ | QoQ Change⇅ | Quarter⇅ |
|---|---|---|---|---|---|---|---|---|
| CITADEL ADVISORS LLC CIK 0001423053 | Hedge Fund | 20K | $39K | 55.0% | 0.0% | Reduced | $-13K | Q3 2025 |
| BALYASNY ASSET MANAGEMENT LLC CIK 0001218710 | Hedge Fund | 16K | $32K | 45.0% | 0.0% | New | — | Q3 2022 |